PACB

PACB

Pacific Biosciences of California Inc. Common Stock

$1.160+0.000 (0.000%)

即時價格

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$1.160

最高

$1.160

最低

$1.160

交易量

8.25M

公司基本面

交易統計

相關新聞

PR Newswire

Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date

Target ALS, a nonprofit breaking down barriers to amyotrophic lateral sclerosis (ALS) research, has partnered with PacBio (Nasdaq: PACB), a leading...

查看更多
Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date
GlobeNewswire

PacBio to Present at Upcoming Investor Conferences

MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the

查看更多
PacBio to Present at Upcoming Investor Conferences
GlobeNewswire

PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene

MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized

查看更多
PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene
Analyst Upgrades

Piper Sandler Maintains Neutral on Pacific Biosciences, Lowers Price Target to $1.25

Piper Sandler analyst David Westenberg maintains Pacific Biosciences with a Neutral and lowers the price target from $2 to $1.25.

查看更多
Piper Sandler Maintains Neutral on Pacific Biosciences, Lowers Price Target to $1.25
Analyst Upgrades

Stephens & Co. Reiterates Overweight on Pacific Biosciences, Maintains $1.8 Price Target

Stephens & Co. analyst Mason Carrico reiterates Pacific Biosciences with a Overweight and maintains $1.8 price target.

查看更多
Stephens & Co. Reiterates Overweight on Pacific Biosciences, Maintains $1.8 Price Target